Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03373069

Ligand	Ligand name	Chain	PDB	Tanimoto
XE4	1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)	A	2HBH	0.72
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.79
STR	PROGESTERONE	A	1H60	0.7
STR	PROGESTERONE	A,B,C	1YA3	0.7
STR	PROGESTERONE	A,B	2AA6	0.7
STR	PROGESTERONE	A	1MRQ	0.7
STR	PROGESTERONE	A,B	1A28	0.7
STR	PROGESTERONE	A,B	2AA5	0.7
STR	PROGESTERONE	A	2HZQ	0.7
STR	PROGESTERONE	A	1W0F	0.7
STR	PROGESTERONE	A	2ABA	0.7
STR	PROGESTERONE	A,B	3COT	0.7
STR	PROGESTERONE	H	1DBB	0.7
STR	PROGESTERONE	H,L	2O5Y	0.7
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.78
CLR	CHOLESTEROL	A,B	2ZXE	0.75
CLR	CHOLESTEROL	A	1N83	0.75
CLR	CHOLESTEROL	A	2RH1	0.75
CLR	CHOLESTEROL	A	1LRI	0.75
CLR	CHOLESTEROL	A	1ZHY	0.75
CLR	CHOLESTEROL	A	3D4S	0.75
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.76
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.86
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.86
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.86
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.86
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.73
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.73
TX5	(1R,3R)-5-((Z)-2-((1R,7AS)-HEXAHYDRO-1-((S)-6-HYDROXY-6-METHYLHEPT-4-YN-2-YL)-7A-METHYL-1H-INDEN-4(7AH)-YLIDENE)ETHYLIDENE)CYCLOHEXANE-1,3-DIOL	A	1TXI	0.72
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.83
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.83
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.83
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.83
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.83
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.83
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.83
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.9
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.9
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.9
VD4	(1R,3R,7E,17Z)-17-(5-hydroxy-1,5-dimethylhexylidene)-2-methylene-9,10-secoestra-5,7-diene-1,3-diol	A	2O4J	0.75
AS4	ALDOSTERONE	A	2AA2	0.84
AS4	ALDOSTERONE	A	2Q1H	0.84
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.75
0MA	maslinic acid	A	2QN2	0.72
GR4		H,I	1AWF	0.72
JC1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXN	0.76
WIN	methyl (5beta,7alpha,9beta,10alpha,11alpha,12alpha,13beta,15alpha)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-3,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicras-3-en-21-oate	0,1,2,3,9,A,B,C,F,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3G71	0.73
COV	(1S,3R,5Z,7E,14beta,17alpha)-17-[(2S,4S)-4-(2-hydroxy-2-methylpropyl)-2-methyltetrahydrofuran-2-yl]-9,10-secoandrosta-5,7,10-triene-1,3-diol	A	3CS4	0.73
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.87
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.87
VD1	5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RKG	0.74
TES	TESTOSTERONE	A	1JTV	0.84
TES	TESTOSTERONE	A	2Q7L	0.84
TES	TESTOSTERONE	A	2Q7I	0.84
TES	TESTOSTERONE	A,B	1J96	0.84
TES	TESTOSTERONE	A	2Q7K	0.84
TES	TESTOSTERONE	A,B	1Q13	0.84
TES	TESTOSTERONE	H	1I9J	0.84
TES	TESTOSTERONE	A,B	1AFS	0.84
TES	TESTOSTERONE	H	1VPO	0.84
TES	TESTOSTERONE	A	2Q7J	0.84
TES	TESTOSTERONE	A,B	3BUR	0.84
TES	TESTOSTERONE	A	2AM9	0.84
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.76
BIV	21-NOR-9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, 20-(4-HYDROXY-4-METHYLPENTYL)-, (1A,3B,5Z,7E)	A	2HCD	0.77
OCC	2ALPHA-(3-HYDROXYPROPOXY)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAR	0.74
VD2	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYL-CYCLOHEXANE-1,3-DIOL	A	1RKH	0.75
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.77
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	1SQN	0.78
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	2W8Y	0.78
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.8
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A	1LHV	0.78
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A,B	3D90	0.78
0AS	asiatic acid	A	2QN1	0.72
HC2	20-HYDROXYCHOLESTEROL	A	1ZHW	0.78
PRB	13-ACETYLPHORBOL	A	1PTR	0.75
VD5	(1R,3R,7E,17E)-17-(5-hydroxy-1,5-dimethylhexylidene)-2-methylene-9,10-secoestra-5,7-diene-1,3-diol	A	2O4R	0.75
FUA	FUSIDIC ACID	A	1QCA	0.79
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.79
FUA	FUSIDIC ACID	A,B	2VUF	0.79
DEX	DEXAMETHASONE	A,D	1M2Z	0.84
DEX	DEXAMETHASONE	A,B,C,D	1P93	0.84
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.8
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.8
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.8
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,B	1J78	0.71
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,D	1MZ9	0.71
MVD	2ALPHA-METHYL-1ALPHA,25-DIHYDROXY-VITAMIN D3	A	2HB8	0.77
HC3	25-HYDROXYCHOLESTEROL	A	1ZHX	0.78
VDZ	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RJK	0.77
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.84
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.84
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.84
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.84
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.84
C3O	2ALPHA-PROPOXY-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAS	0.74
ERG	ERGOSTEROL	A	1BXM	0.73
ERG	ERGOSTEROL	A	1ZHZ	0.73
ERG	ERGOSTEROL	A,B	2AIB	0.73
AXT	ASTAXANTHIN	A,B	1GKA	0.7
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.9
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.74
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.78
JB1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXM	0.76
ZK5	9ALPHA-FLUOROCORTISOL	A	1GS4	0.85
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.76
B2S	(3alpha,7alpha)-3,7,15-trihydroxy-12,13-epoxytrichothec-9-en-8-one	A	3B2S	0.74
ASD	4-ANDROSTENE-3-17-DIONE	A,B	3CAS	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A	1QYX	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A,B,C,D	2VCT	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A	1EUP	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P	2VCV	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A	3EQM	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A	1XF0	0.7
V2H	(1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol	A,B	3DL9	0.73
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A	1S0X	0.71
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A	2Q9F	0.71
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A,B,C	2HKA	0.71
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.71
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.79
2OB	CHOLESTERYL OLEATE	A	2OBD	0.74
MC9	CALCIPOTRIOL	A	1S19	0.72
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZBZ	0.77
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RK3	0.77
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1DB1	0.77
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE9	0.77
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2HC4	0.77
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZLC	0.77
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	3CV9	0.77
EB1	SEOCALCITOL	A	1S0Z	0.75
0CO	(1S,3R,5Z,7E,14beta,17alpha,23R)-23-(2-hydroxy-2-methylpropyl)-20,24-epoxy-9,10-secochola-5,7,10-triene-1,3-diol	A	3CS6	0.73
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1E3G	0.75
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A,B	1E3K	0.75
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	2AO6	0.75
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XOW	0.75
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XQ3	0.75
C0R	CORTICOSTERONE	A	2A3I	0.86
C0R	CORTICOSTERONE	A,B	1Y5R	0.86
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.85
CO1	17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL	A,B	1P8D	0.74
C33	2ALPHA-PROPYL-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAM	0.77
DOG	DIGOXIGENIN	A	1LKE	0.75
DTX	DIGITOXIGENIN	A	1LNM	0.74
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.84
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.84
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.84